Morphoceuticals raises $8m to advance electroceutical approach to regenerative medicine

Biotech company Morphoceuticals has announced it closed an $8 million Seed-2 funding round led by Prime Movers Lab and initial investor Juvenescence.  Seed funding will advance programs using electroceuticals in limb regeneration and amputation stump health.

Read the full article in Longevity Technology.